South KoreaResearch and clinical trials
86 LAM patients from South Korea: lung function is mostly preserved at diagnosis
A study published in a journal and reviewed by independent scientists. Even so, a single study is not conclusive; it needs to be replicated.
In South Korea, 86 women with LAM from 20 centers were studied. Their average age was 47. Half of the patients had no symptoms at diagnosis. 29% had a collapsed lung. Overall, no marked decline in lung function was seen during follow-up.
What does it mean for patients and families?
LAM may not progress quickly in every patient. Those who first see a doctor because of a cough may have a higher risk of progression; the follow-up plan is made with a lung specialist (pulmonologist).
Source
PubMed (Lung): Clinical Characteristics and Outcomes of Patients with Lymphangioleiomyomatosis.
Scientific paper: Clinical Characteristics and Outcomes of Patients with Lymphangioleiomyomatosis. Lung, 2026. DOI: 10.1007/s00408-026-00944-5 · PubMed 42832099
The source page was opened and read on October 7, 2026. Summary prepared by the Doktorclub editorial team and translated from Turkish; it has not yet been reviewed by a physician (a scientific board is being set up).
This page is translated from the Turkish original.
Related disease: Lymphangioleiomyomatosis (LAM)
This page reports a development; it is not a treatment recommendation. Your doctor decides whether a treatment is right for you.